RA
GDRX icon

Royce & Associates’s GoodRx Holdings GDRX Stock Holding History

Royce & Associates’s Portfolio GDRX Stock Details GDRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$110K Hold
38,114
– – ﹤0.01% 731
2026
Q1 		$74.7K Buy
38,114
+5,952
+19% +$14K ﹤0.01% 764
2025
Q4 		$87.2K Buy
+32,162
New +$106K ﹤0.01% 753

Other funds holding GDRX

FPM
Francisco Partners Management San Francisco, California $361M AUM 30.56% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SLG
Silver Lake Group Menlo Park, California $4.58B AUM 24.86% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
PTC
Petrus Trust Company Dallas, Texas $1.06B AUM 4.66% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Royce & Associates's GDRX Position: Q2 2026 in Review

Royce & Associates held its GoodRx Holdings (GDRX) position steady in Q2 2026 at 38,114 shares worth $110K. The position accounts for ﹤0.01% of the portfolio, ranked #731.

Royce & Associates first reported a position in GDRX in Q4 2025 and has held it in 3 quarters since. 163 funds tracked by Wall St. Rank hold GDRX as of Q2 2026.

  • Royce & Associates held 38,114 shares of GoodRx Holdings worth $110K as of Q2 2026.
  • Royce & Associates left its GoodRx Holdings share count unchanged in Q2 2026.
  • GoodRx Holdings made up ﹤0.01% of Royce & Associates's portfolio in Q2 2026, its #731 holding.
  • Royce & Associates first reported a position in GoodRx Holdings in Q4 2025 and has held it in 3 quarters since.
  • 163 funds tracked by Wall St. Rank held GoodRx Holdings as of Q2 2026.

Based on Royce & Associates's 13F filing for Q2 2026, filed 14 Aug 2026.